Myeloma plasma cell expression of osteoblast regulatory genes: overexpression of SFRP3 correlates with clinical bone involvement at diagnosis

被引：9
|
作者：
Kristensen, Ida Bruun [1 ,2 ]
Haaber, Jacob [1 ]
Lyng, Maria Bibi [2 ]
Knudsen, Lene Meldgaard [1 ]
Rasmussen, Thomas [3 ]
Ditzel, Henrik Jorn [2 ]
Abildgaard, Niels [1 ]
机构：
[1] Odense Univ Hosp, Dept Hematol, DK-5000 Odense C, Denmark
[2] Univ So Denmark, Inst Mol Med, Odense, Denmark
[3] Herlev Hosp, Dept Haematol, DK-2730 Herlev, Denmark
来源：
LEUKEMIA & LYMPHOMA | 2013年 / 54卷 / 02期
关键词：
MULTIPLE-MYELOMA; MESSENGER-RNA; DISEASE; GROWTH; SYNDECAN-1; MARROW; DKK1;
D O I：
10.3109/10428194.2012.708027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：425 / 427
页数：3
相关论文
共 10 条
  • [1] Myeloma cell expression of 10 candidate genes for osteolytic bone disease.: Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis
    Haaber, Jacob
    Abildgaard, Niels
    Knudsen, Lene Meldgaard
    Dahl, Inger Marie
    Lodahl, Marianne
    Thomassen, Mads
    Kerndrup, Gitte Birk
    Rasmussen, Thomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (01) : 25 - 35
  • [2] Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease
    Kristensen, Ida B.
    Christensen, Jacob Haaber
    Lyng, Maria B.
    Moller, Michael B.
    Pedersen, Lise
    Rasmussen, Lars M.
    Ditzel, Henrik J.
    Abildgaard, Niels
    LEUKEMIA & LYMPHOMA, 2014, 55 (04) : 911 - 919
  • [3] In vivo WNT-signaling antagonist sFRP3 expression in multiple myeloma: Another potential pathway in myeloma bone disease.
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 258 - 258
  • [4] Myeloma cell expression of candidate genes for osteolytic bone disease - Over-expression of DKK1 correlates with clinical bone involvment.
    Haaber, Jacob
    Knudsen, Lene M.
    Dahl, Inger M.
    Abildgaard, Niels
    Lodahl, Marianne
    Rasmussen, Thomas
    BLOOD, 2006, 108 (11) : 973A - 973A
  • [5] DKK-1 and sFRP-3 expression by myeloma cell and bone marrow plasma levels in multiple myeloma and MGUS patients: Potential relationship with bone status.
    Giuliani, Nicola
    Morandi, Francesca
    Tagliaferri, Sara
    Agnelli, Luca
    Todoerti, Katia
    Pedrazzoni, Mario
    Crugnola, Monica
    Deliliers, Giorgio Lambertenghi
    Rizzoli, Vittorio
    Neri, Antonino
    BLOOD, 2006, 108 (11) : 981A - 981A
  • [6] The Level of Circulating Myeloma Cells at Diagnosis Correlates with a Plasma Cell Leukemia-like Phenotype of the Corresponding Myeloma Cells in Bone Marrow
    Bruinink, Davine Hofste Op
    van der Velden, Vincent
    van Duin, Mark
    Beverloo, Berna
    te Marvelde, Jeroen
    den Hollander, Chelsea
    Kuiper, Rowan
    Delforge, Michel
    van Vliet, Martin H.
    van de Donk, Niels W. C. J.
    Avet-Loiseau, Herve
    Moreau, Philippe
    Sonneveld, Pieter
    BLOOD, 2017, 130
  • [7] TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines
    Moreaux, Jerome
    Hose, Dirk
    Jourdan, Michel
    Reme, Thierry
    Hundemer, Michael
    Moos, Marion
    Robert, Nicolas
    Moine, Philippe
    De Vos, John
    Goldschmidt, Hartmut
    Klein, Bernard
    HAEMATOLOGICA, 2007, 92 (06) : 803 - 811
  • [8] Clinical and biological correlates of CD45 expression on bone marrow plasma cells from patients with multiple myeloma.
    Kumar, S
    Rajkumar, SV
    Kimlinger, T
    Greipp, PR
    Witzig, TE
    BLOOD, 2004, 104 (11) : 918A - 918A
  • [9] Diagnostic and Clinical Considerations in Concomitant Bone Marrow Involvement by Plasma Cell Myeloma and Chronic Lymphocytic Leukemia/Monoclonal B-Cell Lymphocytosis
    Alley, Christopher L.
    Wang, Endi
    Dunphy, Cherie H.
    Gong, Jerald Z.
    Lu, Chuanyi M.
    Boswell, Elizabeth L.
    Burchette, James
    Lagoo, Anand S.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (04) : 503 - 517
  • [10] BASED ON DIFFERENTIAL EXPRESSION OF ANGIOGENIC GENES ALONE, BEING POLYCLONAL PLASMABLAST (PPC), BONE MARROW PLASMA CELL (BMPC) AND MULTIPLE MYELOMA CELL (MMC) CAN BE PREDICTED, BUT BEEING EARLY STAGE VS. THERAPY-REQUIRING MULTIPLE MYELOMA CAN NOT
    Hose, D.
    Moreaux, J.
    Meiner, T.
    Rossi, J. -F.
    Benner, A.
    Mahtouk, K.
    Seckinger, A.
    Hei, C.
    Hundemer, M.
    Reme, T.
    Hillengass, J.
    Herde, K.
    Bertsch, U.
    DeVos, J.
    Wenisch, S.
    Pantesco, V.
    Jauch, A.
    Jourdan, E.
    Goldschmidt, H.
    Klein, B.
    Moehler, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 74 - 75
1